Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
As a multi-targeted tyrosine kinase inhibitor, cabozantinib has shown broad appl···【more】
Release date：2025-02-11Recommended：294
The interaction of avatrombopag with other drugs in clinical application has att···【more】
Release date：2025-02-11Recommended：195
Avatrombopag is a thrombopoietic drug that is widely used in the treatment of th···【more】
Release date：2025-02-10Recommended：230
Avatrombopag is a novel thrombopoietin receptor agonist, which has attracted muc···【more】
Release date：2025-02-10Recommended：217
Avatrombopag, as a thrombopoietin receptor agonist, plays an important role in t···【more】
Release date：2025-02-07Recommended：278
Avatrombopag is an important platelet-stimulating drug, and special care should ···【more】
Release date：2025-02-07Recommended：356
Avatrombopag is an innovative drug that has shown significant results in the tre···【more】
Release date：2025-02-06Recommended：246
Avatrombopag is a novel thrombopoietin receptor agonist, and its safety and side···【more】
Release date：2025-02-06Recommended：262
Avatrombopag is a drug used to treat thrombocytopenia, but its side effects are ···【more】
Release date：2025-02-05Recommended：239
Avatrombopag is a drug used to treat thrombocytopenia, but its use may be accomp···【more】
Release date：2025-02-05Recommended：220
Avatrombopag is a novel thrombopoietin receptor agonist, and its therapeutic eff···【more】
Release date：2025-01-22Recommended：237
Avatrombopag is a novel thrombopoietin receptor agonist that has attracted much ···【more】
Release date：2025-01-22Recommended：238
